
MannKind Corporation MNKD
€ 2.24
1.75%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
MannKind Corporation Langfristiger Schuldenstrom 2011-2026 | MNKD
Langfristiger Schuldenstrom Jährlich MannKind Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.11 M | 2.42 M | 1.42 M | 1.3 M | 1.38 M | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.42 M | 1.3 M | 1.73 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
Amgen
AMGN
|
135 M | $ 349.36 | 2.75 % | $ 188 B | ||
|
AlloVir
ALVR
|
316 K | - | 4.14 % | $ 49.1 M | ||
|
Amneal Pharmaceuticals
AMRX
|
6.76 M | $ 12.67 | 2.82 % | $ 3.97 B | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Applied Therapeutics
APLT
|
429 K | - | - | $ 8.42 M | ||
|
argenx SE
ARGX
|
10.8 M | $ 784.45 | 2.48 % | $ 25 B | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Arcutis Biotherapeutics
ARQT
|
294 K | $ 24.45 | 5.07 % | $ 3.11 B | ||
|
AVROBIO
AVRO
|
878 K | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
382 M | - | - | $ 96.9 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.56 M | $ 1.47 | 8.17 % | $ 391 M | ||
|
BeiGene, Ltd.
BGNE
|
20.7 M | - | 0.49 % | $ 251 B | ||
|
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.83 | 1.86 % | $ 9.21 B | ||
|
BioNTech SE
BNTX
|
45 M | $ 91.3 | 1.87 % | $ 27.2 B | ||
|
CymaBay Therapeutics
CBAY
|
7 K | - | - | $ 3.45 B | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
Aytu BioScience
AYTU
|
137 K | $ 2.72 | 5.84 % | $ 17.1 M | ||
|
Avid Bioservices
CDMO
|
1.35 M | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
1.38 M | - | - | $ 1.41 B | ||
|
Cabaletta Bio
CABA
|
3.46 M | $ 3.07 | - | $ 308 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 3.08 | 1.65 % | $ 6.7 B | ||
|
Cerus Corporation
CERS
|
2.9 M | $ 1.93 | 4.89 % | $ 368 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | ||
|
Concert Pharmaceuticals
CNCE
|
1.16 M | - | - | $ 401 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
CTI BioPharma Corp.
CTIC
|
781 K | - | - | $ 1.2 B | ||
|
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M | ||
|
Cellectar Biosciences
CLRB
|
100 K | $ 2.82 | 2.55 % | $ 7.36 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
3.5 M | - | - | $ 2.18 B | ||
|
Dynavax Technologies Corporation
DVAX
|
4.18 M | - | - | $ 2.02 B | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Cyclerion Therapeutics
CYCN
|
3.29 M | $ 3.47 | -0.29 % | $ 8.74 M |